MDXG
MiMedx Group (MDXG)
$15
About MiMedx Group (MDXG)
MiMedx Group, Inc. is a therapeutic biologics company, which engages in the design, manufacture, and marketing of products, and tissue processing services. It serves the wound care, burn, surgical, orthopedic, spine, sports medicine, ophthalmic, and dental sectors of healthcare. Its biomaterial platform technologies include AmnioFix and EpiFix, a tissue allografts derived from amnion and chorion layers of human placental membrane, EpiCord and AmnioCord, a tissue allografts derived from umbilical cord tissue, and AmnioFill, a placental connective tissue matrix derived from the placental disc and other placental tissue. The company was founded on July 30, 1985 and is headquartered in Marietta, GA.
Details
Daily high
$5.19
Daily low
$4.94
Price at open
$5.02
52 Week High
$8.54
52 Week Low
$4.89
Market cap
762.7M
Dividend yield
0.00%
Volume
876,275
Avg. volume
1.2M
P/E ratio
18.86
MiMedx Group News
Details
Daily high
$5.19
Daily low
$4.94
Price at open
$5.02
52 Week High
$8.54
52 Week Low
$4.89
Market cap
762.7M
Dividend yield
0.00%
Volume
876,275
Avg. volume
1.2M
P/E ratio
18.86